How Yang was paid
$792,000 in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Total |
|---|---|---|---|
| Alex YangChief Executive Officer | — | $792,000 | $792,000 |
| Lisa BollingerChief Medical Officer | $62,500 | $420,000 | $482,500 |
| G. Michael LandisChief Financial Officer | $46,667 | $264,000 | $310,667 |
What changed and why
- $792K$792,000 was CEO Alex Yang’s 2025 total compensation, compared with $580,000 in 2024.
- $792K$792,000 of the CEO’s 2025 compensation consisted of stock awards; no salary was reported.
- 1,800,000 RSUs were granted to Alex Yang on September 1, 2025, before the reverse stock split.
- 20%20% was the target annual bonus percentage for Dr. Bollinger and Mr. Landis under their offer letters.
- July 19, 2026 was Dr. Bollinger’s effective resignation date as Chief Medical Officer.
- 2025 RSUs generally vest over four years and are not deliverable until a qualifying change in control.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.